Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry researchers · Thursday, May 29, 2025 · 817,264,089 Articles · 3+ Million Readers

Elastography Imaging Market Set to Reach $11.84B by 2031, Driven by AI and Global Adoption | DataM Intelligence

Elastography Imaging Market

Elastography Imaging Market

Explore the fast-growing elastography imaging market, driven by non-invasive diagnostics, AI integration, and global healthcare advancements.

With a CAGR of 8.6%, elastography imaging is set to grow from $3.8B in 2023 to $11.84B by 2031 reshaping diagnostics with precision and non-invasive innovation.”
— DataM Intelligence

AUSTIN, TX, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- The Elastography imaging market was valued at USD 3.8 billion in 2023 and is anticipated to grow to approximately USD 11.84 billion by 2031, registering a compound annual growth rate (CAGR) of about 8.6% between 2024 and 2031. This impressive expansion is driven by the increasing use of elastography in diverse clinical applications.

Download Exclusive Sample Report Here: https://www.datamintelligence.com/download-sample/elastography-imaging-market

Elastography imaging is undergoing a major transformation worldwide, fueled by the growing emphasis on early disease detection, minimally invasive diagnostic methods, and rapid advancements in imaging technology. By measuring the elasticity or stiffness of soft tissues, this technique has become particularly valuable for diagnosing conditions such as liver fibrosis, various cancers, and musculoskeletal disorders. The rising global burden of chronic diseases and the push for more precise, patient-friendly diagnostic tools are key factors propelling market growth.

Market Drivers and Trends

Non-Invasive Diagnostics on the Rise
One of the key drivers of elastography imaging adoption is its non-invasive nature. Unlike traditional biopsies, elastography allows clinicians to evaluate tissue conditions such as fibrosis or malignancy without the need for surgical intervention. This reduces patient risk, discomfort, and overall healthcare costs.

Application Expansion
Initially popularized in hepatology for liver fibrosis assessment, elastography is now widely used in oncology, cardiology, urology, and orthopedics. The integration of elastography with conventional ultrasound and magnetic resonance imaging (MRI) has created more precise imaging systems that provide better anatomical and functional insights.

Integration with AI and Machine Learning
Technological innovations such as artificial intelligence (AI) and machine learning are playing a crucial role in improving the accuracy and usability of elastography systems. AI-powered elastography tools can assist in real-time analysis, reducing dependency on operator expertise and providing faster and more consistent diagnostic results.

Regional Outlook

North America
North America, especially the United States, continues to dominate the global elastography imaging market. Factors contributing to this include a well-established healthcare infrastructure, strong focus on research and development, and high adoption rates of advanced imaging technologies. The presence of leading medical device manufacturers and supportive regulatory frameworks also fuel market growth in the region.

Europe
Europe represents another strong market, with Germany, France, and the United Kingdom leading in medical imaging adoption. National healthcare programs and rising investment in diagnostic imaging further bolster the market in this region.

Asia-Pacific
The Asia-Pacific region is projected to experience the most rapid growth during the forecast period. Rising healthcare expenditure, a growing geriatric population, and the increasing incidence of chronic diseases are encouraging healthcare providers in countries such as China, India, and South Korea to adopt elastography imaging. Additionally, government initiatives aimed at improving healthcare access are expected to contribute to regional growth.

Latin America and Middle East & Africa
These regions are gradually gaining traction due to expanding healthcare services, rising awareness of non-invasive diagnostics, and increased investment from both public and private entities. While adoption remains lower than in developed countries, emerging economies show strong long-term potential.

Key Players

GE Healthcare

Siemens Healthineers

Philips Healthcare

Samsung Healthcare

Fujifilm Healthcare

Canon Medical System

Shenzhen Mindray

Esaote SpA

Hologic Inc

Resoundant Inc

Latest News – USA

In the United States, elastography imaging continues to gain momentum across hospitals and diagnostic centers. Several large healthcare institutions are now integrating elastography into their liver health and oncology screening protocols. More recently, U.S.-based imaging firms have introduced next-generation ultrasound systems that feature shear wave elastography, offering enhanced diagnostic accuracy and user-friendly interfaces.

AI-assisted elastography is also gaining traction, with American startups developing solutions that use deep learning to automate image interpretation and deliver quantitative results more rapidly. Furthermore, reimbursement policies for elastography procedures are improving, making the technology more accessible to a broader range of healthcare providers.

The U.S. market is expected to remain at the forefront of global innovation due to its focus on early diagnosis, patient comfort, and high clinical standards.

Latest News – Japan

Japan is emerging as a vital hub for elastography imaging innovation, particularly in ultrasound and MRI applications. The country’s aging population and rising cases of liver and prostate diseases are driving demand for more efficient diagnostic tools. Japanese imaging companies are pioneering compact, portable elastography systems tailored for outpatient and rural settings.

In recent months, several university hospitals in Japan have initiated pilot programs to evaluate the integration of 3D elastography in breast cancer screening. Additionally, Japanese researchers are advancing fusion imaging techniques that combine elastography with contrast-enhanced ultrasound, providing comprehensive insights into tumor characteristics.

Market Segmentation:

By Modality: Ultrasound Elastography, Magnetic Resonance Elastography.

By Mode: Portable, On-platform.

By Application: Radiology, Cardiology, Gynecology/ Obstetrics, Vascular, Orthopedic, and Musculoskeletal, Others.

By End-User: Hospitals, Ambulatory Surgery Center, Diagnostic Center.

By Region: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Conclusion

The elastography imaging market is on a strong upward trajectory, underpinned by the growing demand for early, accurate, and non-invasive diagnostics. From hepatology to oncology and beyond, elastography is proving to be a versatile tool that improves clinical outcomes while reducing patient discomfort.
As innovation accelerates in regions like the USA and Japan, and emerging markets begin to embrace advanced imaging solutions, the elastography imaging sector is poised to become a cornerstone of modern diagnostic medicine.

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Related Reports:

Ultrasound Transducer Market

Veterinary Ultrasound Market

Sai Kumar
DataM Intelligence 4market Research LLP
+1 877-441-4866
email us here
Visit us on social media:
LinkedIn
X

Powered by EIN Presswire

Distribution channels: Healthcare & Pharmaceuticals Industry

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release